You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 284 No. 11, September 20, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communication
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (20)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related articles
 •Similar articles in JAMA

Lead Content of Calcium Supplements

Edward A. Ross, MD; Nancy J. Szabo, PhD; Ian R. Tebbett, PhD

JAMA. 2000;284:1425-1429.

Context  Substantial quantities of lead have been reported in some over-the-counter calcium supplement preparations, including not only bonemeal and dolomite, but also over-the-counter natural and refined calcium carbonate formulations. Examination of this issue is warranted given recent increases in physician recommendations for calcium supplements for prevention and treatment of osteoporosis.

Objectives  To determine the lead content of calcium supplements and to quantify the lead exposure from popular brands of calcium in dosages used for childhood recommended daily allowance, osteoporosis, and phosphate binding in dialysis patients.

Design and Setting  Analysis of lead content in 21 formulations of nonprescription calcium carbonate (including 7 natural [ie, oyster shell] and 14 refined), 1 brand of prescription-only calcium acetate, and 1 noncalcium synthetic phosphate binder conducted in March 2000.

Main Outcome Measures  Lead content, assayed using electrothermal atomic absorption, expressed as micrograms of lead per 800 mg/d of elemental calcium, per 1500 mg/d of calcium, and for a range of dosages for patients with renal failure. Six µg/d of lead was considered the absolute dietary limit, with no more than 1 µg/d being the goal for supplements.

Results  Four of 7 natural products had measurable lead content, amounting to approximately 1 µg/d for 800 mg/d of calcium, between 1 and 2 µg/d for 1500 mg/d of calcium, and up to 10 µg/d for renal dosages. Four of the 14 refined products had similar lead content, including up to 3 µg/d of lead in osteoporosis calcium dosages and up to 20 µg/d in high renal dosages. No lead was detected in the calcium acetate or polymer products. Lead was present even in some brand name products from major pharmaceutical companies not of natural oyster shell derivation.

Conclusions  Despite increasingly stringent limits of lead exposure, many calcium supplement formulations contain lead and thereby may pose an easily avoidable public health concern.


Author Affiliations: Division of Nephrology, Hypertension, and Transplantation, College of Medicine (Dr Ross), and Analytical Toxicology Core Laboratory, Department of Physiological Sciences, College of Veterinary Medicine (Drs Szabo and Tebbett), University of Florida, Gainesville.


RELATED LETTER

Lead in Calcium Supplements
Edward A. Ross, Nancy J. Szabo, Ian R. Tebbett, H. J. Roberts, and Robert P. Heaney
JAMA. 2000;284(24):3126.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Lead in Calcium Supplements: Cause for Alarm or Celebration?
Robert P. Heaney
JAMA. 2000;284(11):1432-1433.
EXTRACT | FULL TEXT  

September 20, 2000
JAMA. 2000;284(11):1451-1452.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Review of Dietary Supplement-Induced Renal Dysfunction
Gabardi et al.
CJASN 2007;2:757-765.
ABSTRACT | FULL TEXT  

Herbal Product Contamination and Toxicity
Smolinske
Journal of Pharmacy Practice 2005;18:188-208.
ABSTRACT  

The Importance of Meeting Calcium Needs with Foods
Miller et al.
J. Am. Coll. Nutr. 2001;20:168S-185.
ABSTRACT | FULL TEXT  

Lead in Calcium Supplements
Ross et al.
JAMA 2000;284:3126-3126.
FULL TEXT  

Lead in Calcium Supplements: Cause for Alarm or Celebration?
Heaney
JAMA 2000;284:1432-1433.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.